# Ronglai Shen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ronglai-shen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,868 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 31 |
| i10-index | 49 |
| OpenAlex ID | https://openalex.org/A5055884560 |
| ORCID iD | https://orcid.org/0000-0001-9694-584X |
| Works | 260 |

## Researcher papers

- [Tumor mutational load predicts survival after immunotherapy across multiple cancer types](https://scholariq.org/papers/tumor-mutational-load-predicts-survival-after-immunotherapy-across-multiple/)
- [Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing](https://scholariq.org/papers/molecular-determinants-of-response-to-anti-programmed-cell-death-pd-1-and-anti/)
- [Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer](https://scholariq.org/papers/overall-survival-with-circulating-tumor-dna-guided-therapy-in-advanced-non-small/)
- [Automated real-world data integration improves cancer outcome prediction](https://scholariq.org/papers/automated-real-world-data-integration-improves-cancer-outcome-prediction/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.